Skip to main content

Table 1 Baseline clinical characteristics

From: The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation

 

LAAT (+)

LAAT (−)

P value

N = 19

N = 278

Age (years), mean ± SD

66 ± 13

62 ± 14

0.37

Age ≥ 75 years, n (%)

5 (26%)

55 (20%)

0.49

Male gender, n (%)

14 (74%)

176 (63%)

0.36

Hypertension, n (%)

16 (84%)

177 (64%)

0.07

Diabetes mellitus, n (%)

8 (42%)

73 (26%)

0.13

Congestive heart failure, n (%)

15 (79%)

132 (47%)

0.01

History of stroke or TIA, n (%)

2 (11%)

27 (10%)

0.91

Aspirin, n (%)

9 (47%)

122 (44%)

0.79

Clopidogrel, n (%)

2 (11%)

16 (6%)

0.41

Antiplatelet, n (%)

10 (53%)

126 (46%)

0.56

Warfarin, n (%)

15 (79%)

148 (53%)

0.03

CHADS 2 score, mean ± SD

2.6 ± 1.2

1.9 ± 1.3

0.009*

CHA 2 DS 2 -VASc Score, mean ± SD

3.5 ± 1.7

2.8 ± 1.8

0.08*

CHADS 2 Score ≥ 2, n (%)

17 (89%)

158 (57%)

0.005

Duration since first AF episode (days), median (interquartile range)

691.5 (90–1163)

162 (4–1249)

0.28*

AF type, n (%)

   

  • Paroxysmal

8 (42%)

153 (55%)

0.27

  • Persistent

4 (21%)

58 (21%)

0.98

  • Permanent

7 (37%)

67 (24%)

0.21

Creatinine (mg/dL), mean ± SD

1.6 ± 0.7

1.4 ± 1.0

0.047*

  1. LAAT: left atrial appendage thrombus; SD: standard deviation; TIA: transient ischemic attack; AF: atrial fibrillation. * Mann–Whitney U test.